Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SCH-900271 is a potent nicotinic acid receptor for the treatment of dyslipidaemia and is commonly used in the study of mixed hyperlipidaemia and primary hypercholesterolaemia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 120.00 | |
5 mg | In stock | $ 290.00 | |
10 mg | In stock | $ 440.00 | |
25 mg | In stock | $ 728.00 | |
50 mg | In stock | $ 987.00 | |
100 mg | In stock | $ 1,390.00 | |
500 mg | In stock | $ 2,770.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 276.00 |
Description | SCH-900271 is a potent nicotinic acid receptor for the treatment of dyslipidaemia and is commonly used in the study of mixed hyperlipidaemia and primary hypercholesterolaemia. |
In vivo | In mice, SCH900271 could lowered FFAs acutely in humans ; however, neither had the expected effects on serum lipids. Chronic FFA suppression was not sustainable via GPR109A agonism with SCH900271.[2] |
Synonyms | SCH 900271 |
Molecular Weight | 276.29 |
Formula | C14H16N2O4 |
CAS No. | 915210-50-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 4.4 mg/mL (15.93 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SCH-900271 915210-50-3 Neuroscience AChR SCH 900271 SCH900271 inhibitor inhibit